Limited data in the pediatric population suggest that early glargine administration in DKA is feasible and results in a faster resolution of the acidosis and a lower total dose of IV insulin without an increased risk of hypoglycemia or cerebral edema,22, 23 though there may be an increased risk of hypokalemia.23 This evidence concerns the gene INS and Hypokalemia.